Inactive Instrument

Official Publications Galapagos NV Euronext Bruxelles

Equities

Real-time Estimate Tradegate Other stock markets 07:38:40 2024-06-04 am EDT			5-day change	1st Jan Change
25.42 ^EUR	0.00%		0.00%	0.00%

May. 31	Galapagos, Adaptimmune to Jointly Develop Head, Neck Cancer Treatment	MT
May. 31	Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug	MT

1st quarter results	May. 01	CO
Minutes of the general assembly	Apr. 29	CO
Annual ESG Report	Mar. 28	CO
Annual ESG Report	Mar. 27	CO
Mixed general shareholder meeting	Mar. 27	CO
Mixed general shareholder meeting	Mar. 27	CO
Annual Report	Mar. 27	CO
Annual Report	Mar. 27	CO
Changes in management and corporate officers	Mar. 25	CO
Changes in management and corporate officers	Mar. 25	CO
Annual results	Feb. 21	CO
Annual results	Feb. 21	CO
Changes in management and corporate officers	Dec. 05	CO
3rd quarter results	Nov. 01	CO
3rd quarter results	Nov. 01	CO
Changes in management and corporate officers	23-09-18	CO
Changes in management and corporate officers	23-09-18	CO
1st-half-year results	23-08-02	CO
Half-year report	23-08-02	CO
Half-year report	23-08-02	CO
Changes in management and corporate officers	23-06-14	CO
Changes in management and corporate officers	23-06-14	CO
Changes in management and corporate officers	23-06-11	CO
Changes in management and corporate officers	23-06-11	CO
Minutes of the general assembly	23-05-09	CO